Wellington Management Group
CMTA

Wellington Management Group’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Wellington Management Group’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-835,918
Closed -$21.8M – 2188
2019
Q1 		$21.8M Sell
835,918
-1,889,562
-69% -$35.3M ﹤0.01% 991
2018
Q4 		$32.1M Buy
2,725,480
+103,681
+4% +$1.29M 0.01% 854
2018
Q3 		$29.2M Sell
2,621,799
-3,390
-0.1% -$35.7K 0.01% 962
2018
Q2 		$34.5M Sell
2,625,189
-56,498
-2% -$915K 0.01% 905
2018
Q1 		$40.6M Buy
2,681,687
+629,415
+31% +$10.2M 0.01% 853
2017
Q4 		$39M Buy
2,052,272
+1,220,768
+147% +$20.4M 0.01% 849
2017
Q3 		$14M Buy
+831,504
New +$13.6M ﹤0.01% 1188

Wellington Management Group's CMTA Position: Q2 2019 in Review

Wellington Management Group sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 835,918 shares — an estimated $21.8M sold.

Wellington Management Group first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $40.6M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Wellington Management Group reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Wellington Management Group sold 835,918 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $21.8M.
  • Wellington Management Group first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
  • Wellington Management Group's Clementia Pharmaceuticals Inc. position peaked at $40.6M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Wellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.